Profitability
Weight: 25%
A
87
- 5yr Avg ROIC 21.6%
- Operating Margin Trend +0.53 pp/yr
CPRX
Catalyst Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
B-
66
- 5yr Avg ROE 22.0%
- 5yr Share-Count CAGR 3.7%
Growth Quality
Weight: 25%
A+
98
- 5yr Revenue CAGR 37.7%
- 5yr EPS CAGR 18.8%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A+
98
- 5yr FCF Margin 39.2%
- 5yr FCF/NI Conversion 1.24x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -2.20x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 17.95
Stability
Weight: 5%
C-
48
- EPS Volatility (σ/μ) 0.61
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 4
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 1 new buy; 1 added; 2 trimmed; 1 full exit.
- Holders
- 4
- Avg Δ position
- +46.8%
- New buys
- 1
- Full exits
- 1